"Without question, BioAdvance funding was a critical ingredient for the launch of Melior Discovery. There was simply no comparable funding source for a startup entity such as ours. Melior would not exist today, would not have discovered a new class of candidate diabetes therapeutics, and would not have uncovered new clinical candidates for our pharma partners were it not for funding conduit provided by BioAdvance."
Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA
Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA
News Releases
| 2010 | | | 2009 | | | 2008 | | | 2007 | | | 2006 | | | 2005 | | | 2004 | | | 2003 | | | 2002 | | | 2001 |
2010
|
July 19, 2010 InfrascannerTM Handheld Brain Scanner Gets $2M-Addresses Top Cause of Combat Death |
| > View Press Release |
|
June 2, 2010 Avid Radiopharmaceuticals to Present Clinical Trial Advances in Molecular Imaging of Pathologogic Targets Associated with Alzheimer's Disease, Dementia with Lewy Bodies and Diabetes at SNM Meeting, June 6-9 -- Interim Phase III data to be presented on landmark florbetapir-PET imaging and beta-amyloid pathology correlation study |
| > View Press Release |
|
May 26, 2010 Entrepreneur OnRamp Helps New Life Science Entrepreneurs Chart a Course for Growth |
| > View Press Release |
|
April 5, 2010 PETNET Avid Announcement |
| > View Press Release |
|
April 1, 2010 Entrepreneur OnRamp Program Announced |
| > View Press Release |
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.